Analyst consensus rating

ARS Pharmaceuticals Analyst Rating: Strong Buy

Direct answer

ARS Pharmaceuticals's consensus rating is Strong Buy.

3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $17.00.
Forecast evidence checked November 16, 2026.

Get free ARS Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Current price
$3.89
Average price target
$17.00
High price target
$20.00
Low price target
$14.00
Low target gap
+259.9%
Target upside
+337%
High target gap
+414.1%
Target range width
154.2%
Consensus rating
Strong Buy
Analysts
3
Evidence date
November 16, 2026
Valid through
November 23, 2026

Read the frequently asked questions.

What is the analyst consensus rating for ARS Pharmaceuticals?

ARS Pharmaceuticals has a verified Strong Buy consensus. The same dataset has an average price target of $17.00.

How far are ARS Pharmaceuticals's low and high targets from the recorded price?

The low target implies +259.9%, while the high target implies +414.1%.

How many analysts are included in ARS Pharmaceuticals's consensus?

The verified consensus includes 3 analysts.

How is ARS Pharmaceuticals's target upside or downside calculated?

The average target of $17.00 is divided by the recorded price of $3.89, then one is subtracted to produce +337%. This does not guarantee a future return.

When was ARS Pharmaceuticals's analyst forecast verified?

The data was verified on 2026-11-16. The dataset is valid through 2026-11-23.